Beyond hypertension toward guidelines for cardiovascular risk reduction.

Area of Science:

• Cardiology
• Preventive Medicine
• Clinical Risk Assessment

Background:

• Current clinical guidelines predominantly manage individual cardiovascular risk factors like hypertension, hypercholesterolemia, and diabetes.
• A comprehensive evaluation of a patient's overall risk profile is crucial for effective cardiovascular disease risk reduction.
• Global risk assessment provides a more appropriate clinical approach to stratify individual patient risk.

Purpose of the Study:

• To demonstrate the implications of shifting from a single risk factor-based approach to a global risk assessment model for hypertension management.
• To advocate for the use of global cardiovascular risk as the primary determinant for treatment decisions in clinical practice and guidelines.

Main Methods:

• Utilized case studies to illustrate the impact of replacing traditional single risk factor management with global risk assessment.
• Compared treatment recommendations based on isolated blood pressure levels versus comprehensive risk profiles.

Main Results:

• Case studies showed that treatment decisions vary significantly when considering the entire risk profile, not just individual factors.
• Patients with mildly elevated blood pressure may not require antihypertensive drug treatment under a global risk assessment model, while others with lower blood pressure might.

Conclusions:

• Propose replacing the single risk factor-based approach with global cardiovascular risk assessment in clinical management.
• Advocate for integrating global risk assessment into clinical practice and future guidelines for improved cardiovascular disease prevention.